Tomas Eriksson

Tomas Eriksson appears in our data through filings on Enorama Pharma AB shares, published by Finansinspektionen. Over a trading history stretching from 9 November 2018 to 15 November 2018, the count stands at 3 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 15 November 2018, the filings show a transaction in Enorama Pharma AB. Filings reach the Finansinspektionen feed a median of 3 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.